Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm based in Irvine, California, specializing in innovative therapies for autoimmune diseases and amyotrophic lateral sclerosis (ALS), particularly those requiring organ or cell transplants. With a strong pipeline of proprietary drug candidates undergoing thorough clinical trials, Eledon addresses pressing unmet medical needs in these high-stakes domains. The company’s strategic emphasis on improving transplant outcomes positions it to make a substantial impact in the biopharmaceutical sector, aiming to enhance the quality of life for patients facing significant health challenges. Show more

Location: 19800 MACARTHUR BOULEVARD, IRVINE, CA, UNITED STATES, 92612, Irvine, CA, 92612, USA | Website: https://eledon.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

175.2M

52 Wk Range

$1.35 - $4.96

Previous Close

$2.15

Open

$2.14

Volume

535,061

Day Range

$2.12 - $2.24

Enterprise Value

78.53M

Cash

3.669M

Avg Qtr Burn

-14.48M

Insider Ownership

1.09%

Institutional Own.

57.61%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tegoprubart (AT-1501) Details Kidney transplantation	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details Type 1 diabetes, Islet Cell Transplantation	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details Amyotrophic lateral sclerosis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details Kidney transplantation	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details Autoimmune nephritis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details IgA nephropathy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.